Table 1.

Demographic and clinical characteristics of women diagnosed with low-grade serous carcinoma in the Ovarian Cancer Association Consortium cohort

Characteristic	No. (%*) of women† n = 707
Age at diagnosis, yr
Mean ± SD	54.2 ± 13.7
Median (range)	54 (18–85)
FIGO stage (n = 659)
I	156 (23.7)
II	64 (9.7)
III	395 (59.9)
IV	44 (6.7)
Residual disease after cytoreductive surgery (n = 391)
No visible disease/complete microscopic resection	200 (51.2)
Any visible residual disease‡	177 (45.3)
Tumour not resected (e.g., inoperable, biopsy only)	14 (3.6)
Received first-line platinum-based chemotherapy (n = 361)
Yes	330 (91.4)
No	31 (8.6)

FIGO = International Federation of Obstetrics and Gynecology; SD = standard deviation.

^*Based on information available for each variable.

^†Except where noted otherwise.

^‡Less than 1 cm: n = 65; 1–2 cm: n = 1; less than 2 cm with no further details: n = 12; greater than 2 cm: n = 23; greater than 1 cm with no further details: n = 2; size unknown: n = 74.